Jefferies Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.23M | Buy |
+20,000
| New | +$1.26M | 0.01% | 759 |
|
|
2022
Q2 | – | Sell |
-220,500
| Closed | -$13.1M | – | 1658 |
|
|
2022
Q1 | $13.1M | Sell |
220,500
-259,300
| -54% | -$16.6M | 0.08% | 190 |
|
|
2021
Q4 | $34.8M | Buy |
479,800
+223,300
| +87% | +$15.4M | 0.2% | 77 |
|
|
2021
Q3 | $17.9M | Buy |
256,500
+56,300
| +28% | +$3.96M | 0.13% | 143 |
|
|
2021
Q2 | $13.8M | Hold |
200,200
| – | – | 0.09% | 195 |
|
|
2021
Q1 | $12.9M | Buy |
+200,200
| New | +$12.9M | 0.11% | 145 |
|
|
2020
Q4 | – | Sell |
-124,900
| Closed | -$7.89M | – | 1646 |
|
|
2020
Q3 | $7.89M | Sell |
124,900
-215,400
| -63% | -$14.9M | 0.09% | 187 |
|
|
2020
Q2 | $26.2K | Sell |
340,300
-75,200
| -18% | -$5.76M | 0.31% | 40 |
|
|
2020
Q1 | $31.1M | Buy |
415,500
+44,800
| +12% | +$3.1M | 0.34% | 36 |
|
|
2019
Q4 | $24.1M | Buy |
370,700
+208,800
| +129% | +$13.6M | 0.19% | 86 |
|
|
2019
Q3 | $10.3M | Sell |
161,900
-3,500
| -2% | -$229K | 0.08% | 214 |
|
|
2019
Q2 | $11.2M | Buy |
165,400
+97,200
| +143% | +$6.39M | 0.08% | 202 |
|
|
2019
Q1 | $4.43M | Sell |
68,200
-193,400
| -74% | -$12.9M | 0.04% | 491 |
|
|
2018
Q4 | $16.4M | Sell |
261,600
-1,700
| -0.6% | -$119K | 0.13% | 113 |
|
|
2018
Q3 | $20.3M | Buy |
263,300
+34,700
| +15% | +$2.62M | 0.13% | 129 |
|
|
2018
Q2 | $16.2M | Buy |
228,600
+216,300
| +1,759% | +$15.3M | 0.09% | 146 |
|
|
2018
Q1 | $927K | Sell |
12,300
-19,000
| -61% | -$1.51M | 0.01% | 1239 |
|
|
2017
Q4 | $2.24M | Buy |
+31,300
| New | +$2.38M | 0.01% | 935 |
|
|
2017
Q3 | – | Sell |
-3,400
| Closed | -$241K | – | 2440 |
|
|
2017
Q2 | $241K | Sell |
3,400
-18,900
| -85% | -$1.26M | ﹤0.01% | 1975 |
|
|
2017
Q1 | $1.51M | Buy |
22,300
+20,900
| +1,493% | +$1.47M | 0.01% | 1058 |
|
|
2016
Q4 | $100K | Sell |
1,400
-37,300
| -96% | -$2.77M | ﹤0.01% | 2018 |
|
|
2016
Q3 | $3.06M | Sell |
38,700
-15,600
| -29% | -$1.27M | 0.02% | 744 |
|
|
2016
Q2 | $4.53M | Sell |
54,300
-69,700
| -56% | -$6.19M | 0.02% | 523 |
|
|
2016
Q1 | $11.4M | Buy |
124,000
+76,800
| +163% | +$6.93M | 0.07% | 227 |
|
|
2015
Q4 | $4.78M | Buy |
47,200
+18,500
| +64% | +$1.92M | 0.03% | 493 |
|
|
2015
Q3 | $2.82M | Sell |
28,700
-58,100
| -67% | -$6.45M | 0.02% | 739 |
|
|
2015
Q2 | $10.2M | Sell |
86,800
-29,500
| -25% | -$3.22M | 0.05% | 280 |
|
|
2015
Q1 | $11.4M | Buy |
116,300
+48,800
| +72% | +$4.96M | 0.06% | 212 |
|
|
2014
Q4 | $6.36M | Buy |
+67,500
| New | +$6.98M | 0.04% | 358 |
|
|
2014
Q2 | – | Sell |
-300,000
| Closed | -$21.3M | – | 2179 |
|
|
2014
Q1 | $21.3M | Buy |
300,000
+175,100
| +140% | +$13.7M | 0.21% | 90 |
|
|
2013
Q4 | $9.38M | Hold |
124,900
| – | – | 0.06% | 177 |
|
|
2013
Q3 | $7.85M | Hold |
124,900
| – | – | 0.08% | 231 |
|
|
2013
Q2 | $6.4M | Buy |
+124,900
| New | +$6.51M | 0.07% | 206 |
|
Other funds holding GILD
Jefferies Group's GILD Position: Q3 2022 in Review
Jefferies Group opened a new position in Gilead Sciences (GILD) in Q3 2022: 37,506 shares worth $2.31M. The stake represents 0.02% of the portfolio and ranks #555 among its holdings. This is a return to the name: Jefferies Group previously reported a position in GILD as recently as Q1 2022.
Jefferies Group first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $29.9M in Q4 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- Jefferies Group held 37,506 shares of Gilead Sciences worth $2.31M as of Q3 2022.
- Gilead Sciences was a new Jefferies Group position in Q3 2022.
- Gilead Sciences made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #555 holding.
- Jefferies Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's Gilead Sciences position peaked at $29.9M in Q4 2021.
- 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.